Clinical Trials List
Protocol NumberNARI-V09DX-mPDAC
Completed
2025-01-01 - 2027-12-31
Phase I
Recruiting1
ICD-10C25.9
Malignant neoplasm of pancreas, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.9
Malignant neoplasm of pancreas, part unspecified
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- MEI-FANG CHENG Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40-80 participants
-
Global
40-80 participants
